Hackensack, NJ: The Davies Law Firm, P.A. was honored at the 2023 Martindale Hubbell Awards. Robert Davies, the firm’s lead attorney, garnered positive reviews from legal peers, specifically highlighting his commitment to ethics, reliability, and diligence in carrying out professional duties.

The honor is a testament to the work that the Hackensack Divorce Lawyer has been doing to assist clients in navigating the divorce process. It also shows that both the attorney and the firm are positively impacting the legal community in Hackensack, particularly in safeguarding people’s rights and ensuring their voices are heard.

“Bob is a remarkably knowledgeable attorney. He is kind and understanding to his clients and an absolute velvet hammer to his adversaries. He is an advocate in the truest sense of the word- he will listen to your story, evaluate the issues sensitively and carefully, and build a strategy to help you achieve your goals.” – PL Wallach, a satisfied client. (Results may vary depending on your particular facts and legal circumstances.)

The Davies Law Firm, P.A. is dedicated to offering caring and prompt support to individuals and families navigating the divorce journey. The attorney is well-versed in the legal system and handling various family matters, ensuring the protection of the client’s rights.

One of the areas in which the Divorce Lawyer Hackensack offers legal assistance is helping clients settle matters related to child custody and parenting time. In most cases, parents easily come to an understanding, figuring out who will have the main custody and sorting out the time they’ll spend with their kids. However, there are times when these two parties cannot agree. This challenge can make the process expensive, emotionally difficult, and intricate. Nevertheless, despite these challenges, the law firm is skilled at facilitating a seamless resolution.

Equitable distribution is another contentious issue in divorce proceedings. While New Jersey adheres to a fair distribution model, where a judge impartially divides assets acquired during marriage, complications may arise. For instance, if a client inherits assets within the marriage, this scenario presents another dimension where the law firm provides essential legal assistance.

Additionally, the firm guides clients through issues related to college and education for their children. They help clients understand the terms used and gain a deeper understanding of the legal system. Moreover, the firm helps them have an objective point of view and manage expectations.

With The Davies Law Firm, P.A., clients can rely on a commitment to navigating the complexities of divorce with diligence and skill.

About The Davies Law Firm:

The Davies Law Firm, P.A. is a divorce attorney assisting clients in navigating divorce and other legal processes such as child custody and wealth distribution. The recent acknowledgment in the Martindale Hubbell Awards highlights the attorney’s legal skills and commitment to ethical standards, underscoring their dedication to assisting clients in Hackensack.

*Attorney advertising. Results may vary depending on your particular facts and legal circumstances.

Media Contact

Company Name
The Davies Law Firm
Contact Name
Robert Davies
Phone
(201) 820-3460
Address
45 Essex St
City
Hackensack
State
NJ
Postal Code
07601
Country
United States
Website
https://attorneyrobertdavies.com/

comtex tracking

COMTEX_443631503/2737/2023-11-17T14:03:10

Read More →
Share:

–News Direct–

Kiora Pharmaceuticals CEO Brian Strem joined Steve Darling from Proactive to share news the company's plan to broaden the clinical development of KIO-301, a treatment designed for various inherited retinal diseases.

The expansion includes initiating a Phase 2 trial which will be controlled, double-masked, randomized, and will involve an ascending dose. This trial is set to include up to 20 patients suffering from Retinitis Pigmentosa (RP), who will receive doses monthly over a span of 90 days.

Strem explained that this move is propelled by encouraging topline results from a Phase I/II clinical trial, which indicated that KIO-301 is a first-in-class small molecule with significant potential to improve vision for patients with RP, even those with extremely low vision or complete blindness.

Moreover, Kiora Pharmaceuticals has plans to engage with the FDA in the fourth quarter of 2023. The goal of this meeting is to achieve consensus regarding the study designs, endpoints, and additional requirements necessary to conduct further studies in the United States and Europe. These studies would not only target RP but also extend to other inherited retinal diseases such as Choroideremia (CHM) and Stargardt disease.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/breaking-ground-in-vision-restoration-kiora-pharmaceuticals-reveals-promising-results-with-kio-301-178699857

Kiora Pharmaceuticals

comtex tracking

COMTEX_443631008/2655/2023-11-17T13:53:27

Read More →
Share:

–News Direct–

Silver Wolf Exploration President Peter Latta joined Steve Darling from Proactive to share news about the recent milestone achieved by the company the acquisition of an exploration diamond drilling permit for the "El Soldado" southern claim within the Ana Maria Project.

This permit, crucial for advancing the project, was obtained approximately six weeks after the initial application was filed for the El Soldado claim.

In conversation with Proactive, Latta underscored that the company's immediate focus for exploration drilling is centered on El Soldado. This particular claim block is situated in a region known for its rich carbonate replacement deposits (CRD), which are typically of high mineral content.

The exploratory work carried out by Silver Wolf Exploration to date has not only revealed high-grade values but also geological indicators that strongly suggest the presence of a CRD.

Furthermore, Latta disclosed the scope of the drilling endeavor that lies ahead. The planned drill program is extensive, set to span up to 4,800 meters across 16 drill holes. T

he strategic approach involves leveraging historical miner insights and modern exploration methods to pinpoint high-potential areas.

Anticipating drilling to commence in Q1 of the coming year, Silver Wolf aims to uncover valuable insights below the historical workings. Additionally, plans are underway to secure permits for the central claim after the completion of the initial program.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/silver-wolf-exploration-receives-drill-permit-for-el-soldado-claim-at-ana-maria-project-672609387

Silver Wolf Exploration

comtex tracking

COMTEX_443630735/2655/2023-11-17T13:48:56

Read More →
Share:

–News Direct–

MTL Cannabis CEO Mike Perron joined Steve Darling from Proactive to to discuss the ethos and operations of their family-founded company, which places a high value on the quality and potential of the cannabis plant.

The company's focus is primarily on flower-based products, including dry flower and pre-rolls. However, Perron notes that they are also venturing into hash production, leveraging their in-house knowledge and capabilities to broaden their product portfolio.

Perron highlighted to Proactive the significant growth MTL Cannabis has experienced, attributing it to organic business development strategies. Remarkably, until January last year, the company's sales efforts were spearheaded by a single, highly dedicated sales representative.

This individual not only worked with provincial boards but also took personal initiatives to promote the brand to dispensaries and budtenders during weekends.

Furthermore, Perron provided insights into MTL Cannabiss agreement with Canada House Wellness Group, a company deeply rooted in clinics and medical cannabis, originally established by veterans for veterans. The veteran community constitutes a crucial segment of their business, accounting for about 96% of their medical cannabis sales.

Canada House operates 12 clinics across the country, including virtual ones, with a strategic presence near military bases to best serve the veteran population.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/mtl-cannabis-road-to-success-is-based-on-flower-first-philosophy-411984134

MTL Cannabis

comtex tracking

COMTEX_443630468/2655/2023-11-17T13:44:24

Read More →
Share:

–News Direct–

Japan Gold CEO John Proust joined Steve Darling from Proactive to to announce significant developments in the company's mineral exploration initiatives.

The company has seen substantial results from in-fill sampling in a drill hole at the Barrick Alliance Mizobe Project in Southern Kyushu. The results have notably expanded the down-hole width of a broad mineralized interval that was previously identified in the initial framework drill program conducted earlier in the year. The interval now measures 144.0 meters with mineralization grades of 0.7 grams per tonne (g/t) for gold (Au) and 2.1 g/t for silver (Ag), starting from 47.0 meters depth.

Proust expressed satisfaction with the exploration team's progress and announced the commencement of a second drilling phase at the Mizobe Project. This new round involves four additional drill holes aimed at probing the extensions of a largely concealed mineralized system. The team anticipates completing the 1000 meters of drilling by December.

In addition to the drilling efforts, Proust mentioned that other projects are also advancing. A geophysical survey is in progress at the Togi Project in central Honshu. Concurrently, detailed mapping is being carried out at the Hakuryu Project. Furthermore, a comprehensive review of the combined data set from the Aibetsu Project is underway. This set includes mapping, soil samples, and Controlled-source Audio-frequency Magnetotellurics (CSAMT) geophysics, to delineate precise drill targets.

These collective efforts demonstrate Japan Gold's commitment to a multifaceted exploration strategy across its projects.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/japan-gold-announces-additional-core-sampling-extends-mineralization-at-mizobe-project-266502825

Japan Gold

comtex tracking

COMTEX_443630188/2655/2023-11-17T13:38:42

Read More →
Share:

–News Direct–

AMSC CEO Pal Magnussen joined Steve Darling from the Proactive studio at the OTC in New York to discuss the company's transition and investment focus.

Formerly known as the American Shipping Company, AMSC sold its entire Jones Act tanker business, signalling a shift from being a leasing company to an investment-focused entity.

The CEO highlighted the sale and a subsequent special dividend, emphasizing the company's move towards becoming an investment firm.

AMSC now aims to explore opportunities beyond traditional shipping, particularly in the offshore sector. Magnussen sees potential in the offshore industry, citing the positive outlook in the offshore oil sector and the emerging offshore wind sector.

As the company broadens its investment mandate, Magnussen notes the importance of exposure in the United States, where AMSC has historical ties.

The CEO expressed optimism about the industry's response to their strategic shift, noting that the public company status allows for a more diverse range of investment activities compared to the leasing focus.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/amsc-ceo-reveals-strategic-shift-and-exciting-investment-opportunities-in-offshore-sector-563211878

AMSC ASA

comtex tracking

COMTEX_443629782/2655/2023-11-17T13:29:36

Read More →
Share:

–News Direct–

CMC Markets PLC (LSE:CMCX) chief financial officer Albert Soleiman speaks to Thomas Warner from Proactive London after the UK-based financial services company released half-year results for the period ended 30 September.

CMC Markets reported a net operating income of 122.6 million, resulting in a pre-tax loss of 2 million, including a 5.3 million impairment charge. Solomon emphasises progress on the operational front, highlighting the expansion of their Invest UK platform and the launch of the Singapore invest offering.

The 2mln pre-tax loss was largely attributed to subdued client activity due to inflationary pressures and the difficult economic climate.

Soleiman reveals that the company will continue its dividend policy, reflecting confidence in future profitability. Share buybacks remain under consideration by the board as part of capital and shareholder return management.

In closing, Solomon expresses optimism about the company's future, citing ongoing strategic investments and operational synergies. While acknowledging the challenges, he sees significant opportunities ahead for CMC Markets.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/cmc-markets-upbeat-on-future-prospects-despite-mixed-interims-869761235

CMC Markets PLC

comtex tracking

COMTEX_443629557/2655/2023-11-17T13:25:05

Read More →
Share:

–News Direct–

In an exclusive interview with Dr Huma Qamar, chief scientific officer for Medicus Pharma Ltd, exciting developments in skincare and oncology are discussed.

Dr Qamar shares her passion for addressing unmet medical needs, particularly in the field of basal cell carcinoma.

The focus is on SkinJet, a flagship company acquired by Medicus Pharma, utilizing revolutionary microarray needles. The needles, transdermally delivering the chemotherapeutic agent doxorubicin, show promising data in preventing relapse and remission of basal cell carcinoma.

Looking ahead, Dr Qamar outlines the company's goals for 2024, emphasizing the resumption of clinical development activities and recruitment efforts. The aim is to complete the phase two trial and present promising data.

Dr Qamar, driven by a dedication to oncology and patient well-being, discusses the emotional impact of cancer and the hope that Medicus Pharma's contributions will bring positive changes to the lives of patients.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/medicus-pharma-sees-appointment-of-dr-huma-qamar-as-key-to-companys-future-807585014

Medicus Pharma

comtex tracking

COMTEX_443629353/2655/2023-11-17T13:20:33

Read More →
Share:

–News Direct–

Sigma Lithium Corp's CEO, Ana Cabral-Gardner, shared exciting news in a recent interview with Thomas Warner from Proactive.

The company reported a 35% net profit margin in its first operational quarter, showcasing financial resilience in the lithium industry. Despite an 80% decrease in lithium prices, Sigma Lithium achieved a remarkable 37% earnings profit margin, emphasizing its low-cost operations and commitment to profitability.

Cabral-Gardner highlighted their unique product, "triple zero" lithium, with an all-in cost of $530 per ton, generating substantial free cash flow. The product's high purity and environmental sustainability, featuring zero carbon, zero tailings, and zero hazardous chemicals, position Sigma Lithium as a preferred supplier for the European battery market.

With a production capacity of 270,000 tonnes and additional low-grade byproducts, the company stands as a major player in the lithium concentrate sector.

Cabral-Gardner expressed pride in Sigma Lithium's triple success low-cost production, environmental leadership, and profitability, making it a resilient force in the industry.

Contact Details

Proactive Canada

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/sigma-lithium-reveals-success-profitable-quarter-environmental-leadership-and-low-cost-production-268527074

Sigma Lithium Corp

comtex tracking

COMTEX_443629094/2655/2023-11-17T13:14:54

Read More →
Share:

–News Direct–

Galliford Try Holdings PLC (LSE:GFRD) chief financial officer Andrew Duxbury speaks to Thomas Warner from Proactive about recent progress with the Sustainable Growth Strategy that the UK construction group first embarked on back in 2021.

Duxbury gives a brief overview of the business and the strategy, aiming to increase revenue from 1.1 billion in 2021 with a 2% operating margin to 1.6 billion with a 3% operating margin by 2026. He says current figures indicate promising growth, with revenue at 1.4 billion and a 31% increase in dividends.

Duxbury emphasises the non-cyclical nature of their work, providing excellent visibility into 2026 despite macroeconomic challenges. He points to recent achievements include a 7 million contract for a build-to-rent scheme at Brent Cross, adding to their robust order book.

Additionally, he says the acquisition of AVRS Systems in the water and energy sector aligns with Galliford Try's strategy, enhancing capabilities and positioning the company well for upcoming procurement cycles.

Duxbury reminds investors of the company's strong financial position, consistent performance, and clear targets up to 2026. He emphasises the robustness of Galliford Try's business model and expressed confidence in its future growth.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/galliford-try-cfo-updates-on-progress-with-sustainable-growth-strategy-752078078

Galliford Try Holdings PLC

comtex tracking

COMTEX_443628882/2655/2023-11-17T13:10:23

Read More →
Share: